<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03142425</url>
  </required_header>
  <id_info>
    <org_study_id>DXT-RADTOX-AC02</org_study_id>
    <secondary_id>261201600051C-0-0-1</secondary_id>
    <nct_id>NCT03142425</nct_id>
  </id_info>
  <brief_title>Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy</brief_title>
  <official_title>Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DxTerity Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>DxTerity Diagnostics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Collect blood samples and associated clinical data prior to and post radiation treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Exploratory study to collect paired pre- and post-irradiation blood samples from 150
      participants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 19, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collection of blood samples from patients prior to and post irradiation treatment.</measure>
    <time_frame>Up to 4 months, from informed consent through follow up activities.</time_frame>
    <description>Explore and validate a radiation sensitivity test for determining radiation treatment tumor response by refining and analyzing gene expression signature of blood samples collected from 150 patients prior to and post irradiation treatment.</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Radiation Therapy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female patients, age 18 or older, diagnosed with a primary rectal or
        esophageal/gastroesophageal junction cancer undergoing radiation therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female patients age 18 or older

          2. Diagnosed with a primary rectal or esophageal cancer

          3. Planned radiation therapy to the esophagogastric area to a minimum of 4140 cGy for
             esophageal/gastroesophageal junction cancer or to pelvis to a minimum of 4500 cGy for
             rectal cancer as part of clinical care

          4. Combining chemotherapy is allowed

          5. ECOG Performance Status 0-2

          6. Able to provide written informed consent

        Exclusion Criteria:

          1. Subjects who have received radiation within three (3) months to esophagogastric or
             pelvic areas prior to consent

          2. Subjects, who in the opinion of the investigator, may not be able to comply with the
             requirements of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Terbrueggen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>President and CEO</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Arruda, B.S.</last_name>
    <phone>310-537-7857</phone>
    <email>aarruda@dxterity.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristen Warren, B.S.</last_name>
    <phone>310-537-7857</phone>
    <email>kwarren@dxterity.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>City of Hope</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bianca Del Vecchio</last_name>
      <phone>626-256-4673</phone>
      <phone_ext>64402</phone_ext>
      <email>bdelvecchio@coh.org</email>
    </contact>
    <investigator>
      <last_name>Yi-Jen Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Group</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandra Baker-Bolden</last_name>
      <phone>323-783-5532</phone>
      <email>sandra.t.baker@kp.org</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Keyte</last_name>
      <phone>323-783-5071</phone>
      <email>jennifer.n.keyte@kp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael R. Girvigian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2017</study_first_submitted>
  <study_first_submitted_qc>May 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>August 23, 2017</last_update_submitted>
  <last_update_submitted_qc>August 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

